<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>5283591 Figure_1-A-B</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 1-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_1-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Immunofluorescence images of MMS22L foci formation at etoposide (ETP)-induced DSBs during S, M and G1 phases of the cell cycle in HeLa cells. Scale bar: 5 &#956;m. B Quantification of a representative experiment from (A) shows number of MMS22L foci per nucleus during indicated cell cycle phases (n = 2; nnuclei &#8805; 60).</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_1-C-D</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 1-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_1-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>C Immunofluorescence images of CPT-induced MMS22L, RPA2, BRCA2 and RAD51 foci in U2OS cells. Scale bar: 5 &#956;m. D Quantification of a representative experiment (n = 3) from (C) shows percentage of &#947;H2AX, RPA2, BRCA2 and RAD51 foci co-localizing with MMS22L foci (nnuclei = 30; nuclei with &#8805; 25 MMS22L foci were analyzed).</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_2-A-B</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 2-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_2-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Electrophoretic mobility shift assay monitoring MMS22L-TONSL binding to ssDNA without RPA and with RPA-coated ssDNA. B Quantification of data as in (A) shows percent MMS22L-TONSL binding to ssDNA with or without RPA, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_2-C</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 2-C</infon>
    <infon key="sourcedata_figure_dir">Figure_2-C</infon>
    <passage>
      <offset>0</offset>
      <text>C Schematic (left) and western blots (right) of streptavidin and NiNTA pulldowns of his-tagged MMS22L-TONSL, RPA and biotinylated ssDNA.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_2-D</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 2-D</infon>
    <infon key="sourcedata_figure_dir">Figure_2-D</infon>
    <passage>
      <offset>0</offset>
      <text>D Yeast two-hybrid analysis shows the effect of deletion of the amino acids 384-522 of MMS22L on the interaction with RPA. The interaction between indicated MMS22L variants fused to LexA DNA-binding domain and RPA1 fused to GAL4 activating domain (GAD) is assessed by survival on media containing 3-aminotriazole (3-AT) in the absence of histidine and by &#946;-galactosidase activity (X-Gal) assays.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_2-E</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 2-E</infon>
    <infon key="sourcedata_figure_dir">Figure_2-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Images of MMS22L foci formed in U2OS cells stably expressing wild-type (WT) or &#916;384-522 variants of siRNA-resistant HSS-MMS22L, depleted of endogenous MMS22L by RNAi and treated with 50 nM CPT for 18 hours. Scale bar: 5 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_3-A</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 3-A</infon>
    <infon key="sourcedata_figure_dir">Figure_3-A</infon>
    <passage>
      <offset>0</offset>
      <text>(A-E) iPOND assays in Hela cells. Experiment schematic (top) and resulting immunoblots (bottom) are shown in (A, B, D) and quantifications are shown in (C, E) with antibodies used for immunoblots indicated throughout. A Abundance of MMS22L-TONSL at active and HU-stalled replication forks, and fully replicated DNA.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_3-B-C</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 3-B-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B-C</infon>
    <passage>
      <offset>0</offset>
      <text>(A-E) iPOND assays in Hela cells. Experiment schematic (top) and resulting immunoblots (bottom) are shown in (A, B, D) and quantifications are shown in (C, E) with antibodies used for immunoblots indicated throughout. B, C MMS22L dynamics at stalled replication forks. Quantification shows average relative abundance of indicated proteins detected in immunoblots, n = 3 except of time-point 5 h, n = 1; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_3-D</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(A-E) iPOND assays in Hela cells. Experiment schematic (top) and resulting immunoblots (bottom) are shown in (A, B, D) and quantifications are shown in (C, E) with antibodies used for immunoblots indicated throughout. D, E Effect of MMS22L depletion on RAD51 levels at stalled replication forks. Quantification shows average relative RAD51 abundance, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_3-E</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(A-E) iPOND assays in Hela cells. Experiment schematic (top) and resulting immunoblots (bottom) are shown in (A, B, D) and quantifications are shown in (C, E) with antibodies used for immunoblots indicated throughout. D, E Effect of MMS22L depletion on RAD51 levels at stalled replication forks. Quantification shows average relative RAD51 abundance, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_4-A-B</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 4-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_4-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Representative immunofluorescence images of foci induced by short CPT treatment (50 nM, 1 h) in U2OS cells treated with indicated siRNAs showing the effect of MMS22L depletion on the RAD51 foci. Scale bar: 5 &#956;m. B Boxplot quantification of representative experiment in (A) (n = 3; nnuclei &#8805; 78). Boxes indicate the 25-75 percentile and whiskers the 10-90 percentile; horizontal lines mark &#8232;the medians. Nuclei with &#8805; 25 &#947;H2AX foci (marker of replication stress sites) were analyzed. Statistical analysis: Mann-Whitney U test; *** P &#8804; 0.0001.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_4-C-F</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 4-C-F</infon>
    <infon key="sourcedata_figure_dir">Figure_4-C-F</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Electron micrographs of a representative reversed fork (C) and a fork with extended ssDNA region at the junction (D) (arrow). P, parental duplex; R, regressed arm. E Frequency of reversed replication forks detected by EM. Similar results were obtained in one independent experiment; n = 2. F Distribution of ssDNA length at replication forks isolated from U2OS cells transfected with the indicated siRNAs and treated with 25 nM CPT for 1h. In brackets, the total number of analyzed molecules is given. Statistical analysis according to Mann-Whitney U test; ** P &#8804; 0.01, n = 2.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-A-B</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-A-B</infon>
    <infon key="sourcedata_figure_dir">Figure_5-A-B</infon>
    <passage>
      <offset>0</offset>
      <text>A Amylose pulldown of MBP (control) or MBP-tagged MMS22L-TONSL and RAD51. Eluate proteins were detected by silver staining. MT: MBP-MMS22L-GST-TONSL. B Quantitative analysis of RAD51 binding to MMS22L-TONSL such as shown in Figure EV6A. Averages shown, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-C</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-C</infon>
    <infon key="sourcedata_figure_dir">Figure_5-C</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Yeast two-hybrid analysis of interactions between LexA DNA binding domain-tagged MMS22L and indicated proteins fused to GAL4 activating domain (GAD) assessed by survival on media containing 3-AT in the absence of histidine and by X-Gal assays.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-D</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-D</infon>
    <infon key="sourcedata_figure_dir">Figure_5-D</infon>
    <passage>
      <offset>0</offset>
      <text>C, D Yeast two-hybrid analysis of interactions between LexA DNA binding domain-tagged MMS22L and indicated proteins fused to GAL4 activating domain (GAD) assessed by survival on media containing 3-AT in the absence of histidine and by X-Gal assays.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-E</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-E</infon>
    <infon key="sourcedata_figure_dir">Figure_5-E</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Streptavidinpulldowns of indicated recombinant proteins and biotinylated ssDNA. The proteins in the input and eluates were detected by western blotting.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-F</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-F</infon>
    <infon key="sourcedata_figure_dir">Figure_5-F</infon>
    <passage>
      <offset>0</offset>
      <text>E, F Streptavidin pulldowns of indicated recombinant proteins and biotinylated ssDNA. The proteins in the input and eluates were detected by western blotting.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-G</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-G</infon>
    <infon key="sourcedata_figure_dir">Figure_5-G</infon>
    <passage>
      <offset>0</offset>
      <text>G Streptavidin pulldown of HSS-tagged MMS22L variants stably integrated and overexpressed in U2OS cells. Input and co-precipitated proteins were detected by immunoblotting.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-H</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-H</infon>
    <infon key="sourcedata_figure_dir">Figure_5-H</infon>
    <passage>
      <offset>0</offset>
      <text>H Representative immunofluorescence images of CPT-induced foci in stable U2OS cell lines depleted of endogenous MMS22L and overexpressing indicated siRNA-resistant variants of HSS-MMS22L treated with 50 nM CPT for 1 hour. Scale bar: 5 &#956;m.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_5-I-J-K</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 5-I-J-K</infon>
    <infon key="sourcedata_figure_dir">Figure_5-I-J-K</infon>
    <passage>
      <offset>0</offset>
      <text>I-K Quantification of the effect of indicated MMS22L mutations on RAD51 foci in U2OS cells treated with 50 nM CPT for 1 h (I; n = 3), 50 nM CPT for 18 h (J; n = 3) or 5 &#181;M ETP for 1 h followed by 3 hours incubation without the drug (K; n = 3). Graphs represent averaged median values; error bars indicate SEM. Statistical analysis according to one-way ANOVA with Bonferroni post-test; *** P &#8804; 0.001; ** P &#8804; 0. 01; ns, not significant. Representative immunofluorescence images are shown in (H), Figures EV6G and EV6H, respectively.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_6-B-C-D</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 6-B-C-D</infon>
    <infon key="sourcedata_figure_dir">Figure_6-B-C-D</infon>
    <passage>
      <offset>0</offset>
      <text>B-D Strand exchange assay with ssDNA and RAD51, and with (C) or without (B) the addition of MMS22L-TONSL (75 nM). D Quantification shows averages, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_6-E</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 6-E</infon>
    <infon key="sourcedata_figure_dir">Figure_6-E</infon>
    <passage>
      <offset>0</offset>
      <text>E Averages of quantified strand exchange assays with ssDNA, RAD51 (270 nM) and varying concentrations of MMS22L-TONSL or MMS22L. n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_6-F</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 6-F</infon>
    <infon key="sourcedata_figure_dir">Figure_6-F</infon>
    <passage>
      <offset>0</offset>
      <text>F Quantification of electrophoretic mobility shift assays with dsDNA or ssDNA, RAD51 and MMS22L-TONSL or MMS22L. Averages shown, n = 2; error bars, SEM.</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_6-H</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 6-H</infon>
    <infon key="sourcedata_figure_dir">Figure_6-H</infon>
    <passage>
      <offset>0</offset>
      <text>H A representative immunoblot showing the effect of increasing amounts of dsDNA on RAD51 binding to ssDNA (1 nM).</text>
    </passage>
  </document>
  <document>
    <id>5283591 Figure_6-I</id>
    <infon key="sourcedata_document">2437</infon>
    <infon key="doi">10.15252/embj.201593132</infon>
    <infon key="pmc_id">5283591</infon>
    <infon key="figure">Figure 6-I</infon>
    <infon key="sourcedata_figure_dir">Figure_6-I</infon>
    <passage>
      <offset>0</offset>
      <text>I A representative immunoblot showing effects of MMS22L-TONSL and MMS22L titration into reactions containing RAD51, ssDNA (1 nM) and dsDNA (10 nM), as indicated.</text>
    </passage>
  </document>
</collection>
